“Partners are working with us to bring manufacturing here. In the near-term, the impact of tariffs won’t be meaningful,” the CEO said.
Related Posts
IBM shares rise 9% on earnings beat
In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.
Spirit makers face a sobering cocktail of challenges — from tariffs to teetotalers
Global spirit makers are staring down a sobering cocktail of challenges as tariffs and brand boycotts threaten to exacerbate wider shifts in drinking habits.